Top broker tips Accent (ASX:AX1) share price to rise 33%

The Accent Group Ltd (ASX: AX1) share price has been a disappointing performer over the last few weeks. Since this …

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Accent Group Ltd (ASX: AX1) share price has been a disappointing performer over the last few weeks.

Since this time in August, the footwear-focused retailer's shares have pulled back by 22%.

This means the Accent share price has wiped out all its 2021 gains and more.

shoes asx share price represented by white shoes against pink and blue background AX1 share price downgrade

Image source: Getty Images

Is the weakness in the Accent share price a buying opportunity?

One leading broker that believes the weakness in the Accent share price is a buying opportunity is Bell Potter.

According to a recent note, the broker has a buy rating and $2.90 price target on the company's shares.

Based on the latest Accent share price of $2.18, this implies potential upside of 33% over the next 12 months before dividends.

And if you include the 9 cents per share fully franked dividend Bell Potter is forecasting in FY 2022, this potential return stretches to over 37%.

What did Bell Potter say?

Although the broker has reduced its forecasts (and price target) to reflect the negative impact of lockdowns, it remains positive on Accent. This is due to its belief that the underlying fundamentals of the business remain strong and attractive.

Bell Potter commented: "We have cut our 1H22 estimates to reflect lockdown impacts. The net effect is our FY22 EPS falls by -21%, although there is no material change in FY23/FY24. Including model roll-forward, our 12-month price target reduces to $2.90 (previously $3.30). Notwithstanding the material near-term lockdown impacts, the underlying fundamentals of the business remain strong and attractive. We retain our Buy rating on the stock."

Despite the recent weakness in the Accent share price, it has still smashed the market on a 12-month basis. During this time the company's shares have risen 37%. This compares to a 22% gain by the S&P/ASX 200 Index (ASX: XJO).

Pleasingly, Bell Potter appears to believe it can do the same again over the next 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »